Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry.
Pöttgen C, Hoffmann C, Gauler T, Guberina M, Guberina N, Ringbaek T, Santiago Garcia A, Krafft U, Hadaschik B, Khouya A, Stuschke M. Pöttgen C, et al. Among authors: hadaschik b. Cancers (Basel). 2023 Oct 11;15(20):4933. doi: 10.3390/cancers15204933. Cancers (Basel). 2023. PMID: 37894299 Free PMC article.
Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study.
Váradi M, Horváth O, Módos O, Fazekas T, Grunewald CM, Niegisch G, Krafft U, Grünwald V, Hadaschik B, Olah C, Maráz A, Furka A, Szűcs M, Nyirády P, Szarvas T. Váradi M, et al. Among authors: hadaschik b. Sci Rep. 2023 Oct 13;13(1):17378. doi: 10.1038/s41598-023-44103-9. Sci Rep. 2023. PMID: 37833455 Free PMC article.
Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various Malignancies.
Hirmas N, Hamacher R, Sraieb M, Kessler L, Pabst KM, Barbato F, Lanzafame H, Kasper S, Nader M, Kesch C, von Tresckow B, Hautzel H, Aigner C, Glas M, Stuschke M, Kümmel S, Harter P, Lugnier C, Uhl W, Hadaschik B, Grünwald V, Siveke JT, Herrmann K, Fendler WP. Hirmas N, et al. Among authors: hadaschik b. J Nucl Med. 2024 Feb 8:jnumed.123.266652. doi: 10.2967/jnumed.123.266652. Online ahead of print. J Nucl Med. 2024. PMID: 38331453
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial).
Nikitas J, Lam E, Booker KA, Fendler WP, Eiber M, Hadaschik B, Herrmann K, Hirmas N, Lanzafame H, Stuschke M, Czernin J, Steinberg ML, Nickols NG, Kishan AU, Calais J. Nikitas J, et al. Among authors: hadaschik b. J Nucl Med. 2024 Apr 25:jnumed.123.267004. doi: 10.2967/jnumed.123.267004. Online ahead of print. J Nucl Med. 2024. PMID: 38664019
Standardized PSMA-PET Imaging of Advanced Prostate Cancer.
Seifert R, Gafita A, Telli T, Voter A, Herrmann K, Pomper M, Hadaschik B, Rowe SP, Fendler WP. Seifert R, et al. Among authors: hadaschik b. Semin Nucl Med. 2024 Jan;54(1):60-68. doi: 10.1053/j.semnuclmed.2023.07.005. Epub 2023 Aug 10. Semin Nucl Med. 2024. PMID: 37573199 Review.
PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading?
Almeida LS, Etchebehere ECSC, García Megías I, Calapaquí Terán AK, Hadaschik B, Colletti PM, Herrmann K, Giammarile F, Delgado Bolton RC. Almeida LS, et al. Among authors: hadaschik b. Clin Nucl Med. 2024 Jan 1;49(1):45-55. doi: 10.1097/RLU.0000000000004919. Epub 2023 Oct 25. Clin Nucl Med. 2024. PMID: 37882758 Review.
Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review.
Gartrell BA, Phalguni A, Bajko P, Mundle SD, McCarthy SA, Brookman-May SD, De Solda F, Jain R, Yu Ko W, Ploussard G, Hadaschik B. Gartrell BA, et al. Among authors: hadaschik b. Eur Urol Oncol. 2024 May 13:S2588-9311(24)00106-8. doi: 10.1016/j.euo.2024.04.016. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38744587 Free article. Review.
403 results